These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9927804)

  • 1. [How to reduce the prevalence of HIV-positive blood donors].
    León G; Hernández T; Quiros AM; Maio A; García L
    Invest Clin; 1998 Dec; 39(4):307-21. PubMed ID: 9927804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum hepatitis B markers in blood donors in Venezuela. What do they mean?].
    León G; Hernández T; García L; Maio A; Quiroz A; Gamboa M
    Sangre (Barc); 1998 Oct; 43(5):385-91. PubMed ID: 9868330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV and blood donors: past, present and future].
    León de González G; Hernández T; Arias F; Celis S; Acosta V; Semprún O; Lugo de Morón M
    Sangre (Barc); 1994 Feb; 39(1):15-21. PubMed ID: 8197513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
    Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
    Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors.
    Barusrux S; Urwijitaroon Y; Puapairoj C; Romphruk A; Sriwanitchrak P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S106-11. PubMed ID: 9347656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the risk of HIV transmission through blood transfusion by donor self-deferral.
    Urwijitaroon Y; Barusrux S; Romphruk A; Puapairoj C; Pakote L
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):452-6. PubMed ID: 9185252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual risk of HIV-1 transmission: the case of a seroconverter.
    Miceli M; Giuliani M; Gallo A; Mercurio G; Crescimbeni E; Iudicone P
    Clin Lab; 2002; 48(5-6):283-6. PubMed ID: 12071578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patient-related blood donors represent a threat to the safety of the blood supply?
    Pereira A; Sanz C; Tàssies D; Ramírez B
    Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the seropositive prevalence of human immunodeficiency virus in a village residents living in rural region of central China].
    Cheng H; Qian X; Cao GH; Chen CK; Gao YN; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):317-21. PubMed ID: 15231200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
    Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood donors seropositive for type 1 human immunodeficiency virus (HIV-1). Epidemiologic characteristics and clinical course].
    Altès A; Muñiz-Díaz E; Madoz P; Verger G; Martino R; Puig L
    Sangre (Barc); 1995 Aug; 40(4):269-74. PubMed ID: 7482114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.
    Minga A; Dohoun L; Abo Y; Coulibaly A; Konaté S; Ouattara HP; N'guessan BK; Dabis F; Salamon R; Lewden C;
    Transfusion; 2010 Apr; 50(4):888-93. PubMed ID: 19951316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
    Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
    Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.